25 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

LAB B

Genomma Lab Internacional. de
Mex$15.10-2.3%5.2%Mex$14.0bMex$21.11PE13.6xE27.1%5.2%

INDV N

Indivior
UK£314.49-51.3%-51.3%UK£1.9bUK£478.88PE14.1xE14.4%0%

REGN *

Regeneron Pharmaceuticals
US$15,794.330%5.8%US$97.2bUS$17,950.30PE24.6xE10.9%n/a

GSK1 N

GSK
UK£357.350%n/aUK£67.2bUK£434.85PE13.6xE9.4%3.5%

INCY *

Incyte
US$986.000%n/aUS$12.1bUS$1,392.62PE20.2xE20.1%n/a

HALO *

Halozyme Therapeutics
US$680.000%0.04%US$5.2bUS$873.74PE20.5xE24.1%n/a

RPRX N

Royalty Pharma
US$482.000%n/aUS$16.9bUS$775.44PE11.1xE6.0%3.0%

SOBI N

Swedish Orphan Biovitrum
kr567.340%0%kr64.7bkr746.39PE20.4xE15.6%n/a

SNY N

Sanofi
€795.000%-21.4%€108.0b€986.01PE20xE14.0%4.3%

ROG N

Roche Holding
CHF4,025.87-0.4%n/aCHF181.2bCHF5,032.83PE15.6xE8.3%4.3%

GSK N

GSK
UK£655.00-7.4%n/aUK£67.2bUK£797.06PE13.6xE9.4%3.5%

2269 N

WuXi Biologics (Cayman)
HK$62.530%n/aHK$61.6bHK$186.38PE13.7xE17.1%n/a

GMAB N

Genmab
kr.5,100.000%n/akr.134.5bkr.6,005.52PE30.9xE21.6%n/a

MRK1 N

Merck KGaA
€2,878.210%n/a€66.8b€3,410.38PE23.6xE10.0%1.4%

PHM1 N

Pharma Mar
€1,608.380%0%€601.5m€2,866.23PE20.9xE26.7%2.0%

GXI N

Gerresheimer
€1,649.750%n/a€3.6b€2,073.48PE31.3xE19.7%1.2%

CRL *

Charles River Laboratories International
US$4,008.35n/an/aUS$12.4bUS$4,495.54PE26.1xE11.4%n/a

AZN1 N

AstraZeneca
UK£2,196.580%-5.5%UK£147.3bUK£2,969.10PE31.2xE17.5%2.4%

QIA N

Qiagen
US$784.350%n/aUS$8.9bUS$995.64PE26.1xE11.2%n/a

A *

Agilent Technologies
US$2,201.290%-17.2%US$40.8bUS$2,292.53PE33xE8.8%0.7%

NVS N

Novartis
CHF1,540.01-4.1%n/aCHF188.6bCHF1,763.21PE24.1xE9.1%3.8%

VRTX *

Vertex Pharmaceuticals
US$6,530.25-6.1%9.0%US$102.5bUS$7,596.10PE28.3xE11.4%n/a

BMRN *

BioMarin Pharmaceutical
US$1,575.000%-10.3%US$17.5bUS$1,879.16PE104.4xE30.5%n/a

4568 N

Daiichi Sankyo Company
JP¥486.510%n/aJP¥7.3tJP¥680.26PE49.7xE26.7%1.0%
Page 1 of 2
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.